I propose to take Questions Nos. 1417, 1418 and 1419 together.
Details of the proposed inquiry into the historical licensing and use of sodium valproate in Ireland, and of the stakeholder group referred to by the Deputy, are currently being considered by officials within the Department of Health.
The HSE recently submitted a request to the Department for four epilepsy nurse specialist posts to assist in the implementation of the Pregnancy Prevention Programme related to the use of sodium valproate in women of child-bearing age. Department officials will consider this request to determine whether funding can be made available in 2022; however, it is also open to the HSE to consider funding these posts from within existing resources.